Northwire Canada EditionSaturday, October 17, 2026
Sign inSubscribe
Northwire
⌕
GOLD 4181.10 +0.3% SILVER 57.30 +0.3% COPPER 6.57 +0.3% OIL 99.02 +1.1% PALLADIUM 1118.60 −0.9% GBU 0.095 +0.0% ATY 0.225 +4.7% GRDM 0.215 +0.0% PPM 0.300 +0.0% GZD 0.040 −11.1% CAN 0.060 +0.0% BGF 0.025 +0.0% MSV 0.570 +0.0% CCMM 0.485 +0.0% MON 0.385 −6.1% OMI 0.245 −2.0% BUFF 0.800 +2.6% FEO 0.630 −3.1% LIB 0.710 −1.4% NPR 0.620 +0.0% QZM 0.380 +0.0% GOLD 4181.10 +0.3% SILVER 57.30 +0.3% COPPER 6.57 +0.3% OIL 99.02 +1.1% PALLADIUM 1118.60 −0.9% GBU 0.095 +0.0% ATY 0.225 +4.7% GRDM 0.215 +0.0% PPM 0.300 +0.0% GZD 0.040 −11.1% CAN 0.060 +0.0% BGF 0.025 +0.0% MSV 0.570 +0.0% CCMM 0.485 +0.0% MON 0.385 −6.1% OMI 0.245 −2.0% BUFF 0.800 +2.6% FEO 0.630 −3.1% LIB 0.710 −1.4% NPR 0.620 +0.0% QZM 0.380 +0.0%

Healthcare

Page 69
  1. Jan 27, 2026 · 16:00 · INNO

    Innocan Pharma Corporation Anticipates Listing on the NYSE American Stock Exchange with Concurrent Offering

    Innocan Pharma Corporation Anticipates Listing on the NYSE American Stock Exchange with Concurrent Offering

    01
  2. Jan 27, 2026 · 15:49 · RKV

    Rakovina Therapeutics Announces Corporate Update Including up to $1.5 Million in New Financing, Leadership Appointments and Debt Restructuring

    Rakovina Therapeutics Announces Corporate Update Including up to $1.5 Million in New Financing, Leadership Appointments and Debt Restructuring

    02
  3. Jan 27, 2026 · 08:30 · NURS

    Hydreight Technologies Inc. Announces Closing of Oversubscribed $15 Million Bought Deal LIFE Offering

    Hydreight Technologies Inc. Announces Closing of Oversubscribed $15 Million Bought Deal LIFE Offering

    03
  4. Jan 27, 2026 · 08:05 · MBIO

    MindBio Targets Global Digital Health Diagnostics Market with World First AI Powered Speech Analytics Technology

    MindBio Targets Global Digital Health Diagnostics Market with World First AI Powered Speech Analytics Technology

    04
  5. Jan 27, 2026 · 08:00 · AIDR

    Rocket Doctor Signs New Contract with Major U.S. Insurer, Expanding Access to an Additional 175,000 Members Across California

    Rocket Doctor Signs New Contract with Major U.S. Insurer, Expanding Access to an Additional 175,000 Members Across California

    05
  6. Jan 27, 2026 · 07:30 · BCT

    BriaCell Highlights Extended >18-47 Months Survival in Phase 2 Metastatic Breast Cancer Patients

    BriaCell Highlights Extended >18-47 Months Survival in Phase 2 Metastatic Breast Cancer Patients

    06
  7. Jan 26, 2026 · 19:00 · SEGN

    SEEGNAL PRESENTS REAL-WORLD EVIDENCE ON REDUCING FALL RISK IN GERIATRIC PATIENTS AT CALTCM SUMMIT

    SEEGNAL PRESENTS REAL-WORLD EVIDENCE ON REDUCING FALL RISK IN GERIATRIC PATIENTS AT CALTCM SUMMIT

    07
  8. Jan 26, 2026 · 18:12 · CHS

    Comprehensive Healthcare Systems Upsizes Non-Brokered Private Placement

    Comprehensive Healthcare Systems Upsizes Non-Brokered Private Placement

    08
  9. Jan 26, 2026 · 17:51 · NPTH

    Neupath Health appoints Lemieux as CEO

    Neupath Health appoints Lemieux as CEO

    09
  10. Jan 26, 2026 · 11:33 · BNXT

    Bionxt moves cladribine ODF to clinic

    Bionxt moves cladribine ODF to clinic

    10
  11. Jan 26, 2026 · 07:31 · CHER

    Cheelcare Announces Medicare and Medicaid Services Reimbursement Approval for Companion Power Assist Device, Expanding U.S. Market Access

    Cheelcare Announces Medicare and Medicaid Services Reimbursement Approval for Companion Power Assist Device, Expanding U.S. Market Access

    11
  12. Jan 26, 2026 · 07:30 · NPTH

    NEUPATH HEALTH ANNOUNCES EXECUTIVE LEADERSHIP CHANGES AS PART OF PLANNED TRANSITION, PRE-ANNOUNCES STRONG 2025 RESULTS

    NEUPATH HEALTH ANNOUNCES EXECUTIVE LEADERSHIP CHANGES AS PART OF PLANNED TRANSITION, PRE-ANNOUNCES STRONG 2025 RESULTS

    12
  13. Jan 26, 2026 · 03:05 · BNXT

    BioNxt Accelerates ODF for Multiple Sclerosis Toward Human Clinical Study with >40% Bioavailability Improvement and Myasthenia Gravis Expansion

    BioNxt Accelerates ODF for Multiple Sclerosis Toward Human Clinical Study with >40% Bioavailability Improvement and Myasthenia Gravis Expansion

    13
  14. Jan 23, 2026 · 20:01 · ONCO

    Onco-Innovations arranges $2-million private placement

    Onco-Innovations arranges $2-million private placement

    14
← Newer Older →